Skip to main content
Ulrike Buchwald, MD, Infectious Disease, Lutherville, MD

UlrikeKirstenBuchwaldMD

Infectious Disease Lutherville, MD

HIV/AIDS Medicine, International Health, Travel & Tropical, Mycobacterial Disease, STD Medicine

Director, Clinical Vaccine Research, Merck & Co Clinical Assistant Professor, Medicine, University of Maryland School of Medicine

Dr. Buchwald is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Buchwald's full profile

Already have an account?

  • Office

    Johns Hopkins Gastroenterology Green Spring Station
    2360 W Joppa Rd
    Lutherville, MD 21093
    Phone+1 410-933-7495

Education & Training

  • London School of Hygiene and Tropical Medicine
    London School of Hygiene and Tropical MedicineMS, Public Health, 2014 - 2019
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Infectious Disease, 2007 - 2010
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Internal Medicine, 2004 - 2007
  • Freie University Berlin Faculty of Medicine
    Freie University Berlin Faculty of MedicineClass of 1998

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2010 - 2026
  • PA State Medical License
    PA State Medical License 2016 - 2018
  • NJ State Medical License
    NJ State Medical License 2010 - 2011
  • NY State Medical License
    NY State Medical License 2009 - 2011
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Press Mentions

  • Pancreatic Cancer Clinical Trials: Insights from PanCAn’s Senior Director
    Pancreatic Cancer Clinical Trials: Insights from PanCAn’s Senior DirectorDecember 16th, 2023
  • CMV Vaccine Trials: Moderna’s CMV mRNA Vaccine Enters Phase III
    CMV Vaccine Trials: Moderna’s CMV mRNA Vaccine Enters Phase IIIFebruary 20th, 2024
  • Merck’s Capvaxive Wins FDA Approval as First Pneumonia Vaccine Designed for Adults
    Merck’s Capvaxive Wins FDA Approval as First Pneumonia Vaccine Designed for AdultsJune 22nd, 2024